Physician

Andy Wei-Hao Su, MD

According to 2025 Medicare claims, Andy Su, MD (NPI: 1699897306) practices radiation oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is FOX VALLEY RADIATION ONCOLOGY LLC (NPI: 1720141047; TIN: 20-5861109) and primary practice location at 60126-5658.

Su's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 139 traditional Medicare patients, billed 2,166 HCPCS/CPT codes, and received $134,990 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 133 prescription claims across 55 beneficiaries totaling $1,719 in drug costs, led by Dexamethasone (Dexamethasone). Open Payments data shows 2 records totaling $68. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $290,567 to $134,990. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $2,609 to $1,719. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$146K$292K2015 Medicare payment: $290,567 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $247,658 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $215,420 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $205,524 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $291,500 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $163,075 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $183,972 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $182,039 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $160,382 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $134,990 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152574,995$290,567
20162184,205$247,658
20172363,762$215,420
20182033,427$205,524
20192424,881$291,500
20201412,697$163,075
20211613,045$183,972
20221903,057$182,039
20231772,671$160,382
20241392,166$134,990

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.8K$5.5K2015 Drug cost: $2,609 (USD; Tot_Drug_Cst)2016 Drug cost: $5,548 (USD; Tot_Drug_Cst)2017 Drug cost: $2,497 (USD; Tot_Drug_Cst)2018 Drug cost: $3,736 (USD; Tot_Drug_Cst)2019 Drug cost: $3,641 (USD; Tot_Drug_Cst)2020 Drug cost: $2,262 (USD; Tot_Drug_Cst)2021 Drug cost: $2,106 (USD; Tot_Drug_Cst)2022 Drug cost: $1,486 (USD; Tot_Drug_Cst)2023 Drug cost: $1,384 (USD; Tot_Drug_Cst)2024 Drug cost: $1,719 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201559112$2,609
201661149$5,548
201751122$2,497
201854176$3,736
201963157$3,641
20203285$2,262
202142120$2,106
20223989$1,486
20234583$1,384
202455133$1,719

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77427Radiation treatment management, 5 treatment sessions59216$154
77263Complex radiation therapy planning7378$136
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6775$51
77334Design and construction of complex radiation treatment device74190$49
77300Calculation of radiation therapy dose71268$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
DexamethasoneDexamethasone36979$540
Tamsulosin HclTamsulosin Hcl302,202$486
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16234$322

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$68Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andy Wei-Hao Su, MD?

Tedicare shows public-source Medicare data for Andy Wei-Hao Su, MD (NPI 1699897306), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andy Wei-Hao Su, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andy Wei-Hao Su, MD?

Andy Wei-Hao Su, MD is linked to FOX VALLEY RADIATION ONCOLOGY LLC (billing NPI 1720141047) in the available physician profile data.

Does Andy Wei-Hao Su, MD have Open Payments data?

Andy Wei-Hao Su, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.